RDGL Company Profile and Key Details

Vivos Inc. (OTC:RDGL) closed at $0.06 USD, losing -$0.02 (-27.95%) from the previous close of $0.08. The stock is currently mid-range between its 52-week high and low $0.04 and $0.15. With a market capitalization of about $29.14 million, Vivos Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.74). Key stats such as the average daily volume over the past year has been around 1.63 million shares, trading with heavier-than-usual volume. Headquartered in Kennewick, WA, Vivos Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Michael K. Korenko, the company employs approximately 1 people and listed since September 02, 1998. Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed.

Average 10-day trading volume of 5.62 million shares is significantly above the 3-month average of 1.74 million, indicating heightened recent market interest.

Vivos Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.03. This means the shares are trading below this model’s fair value.

Our AI price prediction model suggests that Vivos Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Vivos Inc. trading at a premium to the broader market with a P/E of -8.01.

Vivos Inc. trades at a P/E ratio of -8.01, slightly below the S&P 500 average, with a price-to-sales ratio of 382.02 and a price-to-book ratio of 10.3 reflecting a rich premium to book value. The P/FCF stands at -12.98, also below market averages. Compared to sector medians, Vivos Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.